Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Multiple complications and frequent severe hypoglycaemia in 'elderly' and 'old' patients with Type1 diabetes

M. Schütt, E. M. Fach, J. Seufert, W. Kerner, W. Lang, A. Zeyfang, R. Welp, R. W. Holl

Abstract

AIM: Elderly and old patients with Type 1 diabetes represent a growing population that requires thorough diabetes care. The increasing relevance of this subgroup, however, plays only a minor role in the literature. Here, we describe elderly patients with Type 1 diabetes on the basis of a large multi-centre database in order to point out special features of this population.\n\nMETHOD: Data of 64609 patients with Type 1 diabetes treated by 350 qualified diabetes treatment centres were assessed and analysed by age group.\n\nRESULTS: Compared with the age group ≤ 60 years, patients aged >60 years (n=3610 61-80 years and n=377 >80 years old) were characterized by a longer diabetes duration (27.7 vs. 7.7 years), an almost double risk for severe hypoglycaemia (40.1 vs. 24.3/100 patient-years), a lower level of HbA(1c) [60 vs. 67 mmol/mol (7.6 vs. 8.3%)] and higher percentages of microalbuminuria (34.5 vs. 15.6%), diabetic retinopathy (45.2 vs. 8.3%), myocardial infarction (9.0 vs. 0.4%) or stroke (6.8 vs. 0.3%). Elderly patients used insulin pumps less frequently (12.2 vs. 23.8%), but more often used conventional premixed insulin treatment (10.8 vs. 3.8%). Differences between elderly and younger patient groups were significant, respectively.\n\nCONCLUSION: Diabetes care of elderly patients with Type 1 diabetes involves individualized treatment concepts. Increased hypoglycaemia risk and functional impairment attributable to diabetes-associated and/or age-related disorders must be taken into account.
OriginalspracheEnglisch
TitelDiabetic Medicine
Erscheinungsdatum08.2012
ISBN (Print)1464-5491 (Electronic)\r0742-3071 (Linking)
DOIs
PublikationsstatusVeröffentlicht - 08.2012

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 9 – Industrie, Innovation und Infrastruktur
    SDG 9 – Industrie, Innovation und Infrastruktur

Fingerprint

Untersuchen Sie die Forschungsthemen von „Multiple complications and frequent severe hypoglycaemia in 'elderly' and 'old' patients with Type1 diabetes“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren